TrialBMJ global health2021

Effectiveness and safety of reactive focal mass drug administration (rfMDA) using dihydroartemisinin-piperaquine to reduce malaria transmission in the very low-endemic setting of Eswatini: a pragmatic cluster randomised controlled trial.

Sibonakaliso Vilakati et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.